title: Gastrin receptor pharmacology.
abstract: C-terminally amidated gastrins act at cholecystokinin-2 receptors (CCK2R), which are normally expressed by gastric parietal and enterochromaffin-like (ECL) cells and smooth muscle; there is also extensive expression in the CNS where the main endogenous ligand is cholecystokinin. A variety of neoplasms express CCK2R, or splice variants, including neuroendocrine, pancreatic, medullary thyroid and lung cancers. Other products of the gastrin gene (progastrin, the Gly-gastrins) may stimulate cell proliferation but are not CCK2R ligands. Depending on the cell type, stimulation of CCK2R evokes secretion, increases proliferation and cell migration, inhibits apoptosis, and controls the expression of various genes. These effects are mediated by increased intracellular calcium and activation of protein kinase C, MAPkinase and other protein kinase cascades. There has been recent progress in developing CCK2R ligands that can be used for imaging tumours expressing the receptor. New antagonists have also been developed, and there is scope for using these for suppression of gastric acid and for treatment of neuroendocrine and other CCK2R-expressing tumours.
authors.affiliation: Departments of Cell and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK. g.j.dockray@liverpool.ac.uk
authors.forename: Graham J
authors.initials: GJ
authors.lastname: Dockray
authors.forename: Andy
authors.initials: A
authors.lastname: Moore
authors.forename: Andrea
authors.initials: A
authors.lastname: Varro
authors.forename: D Mark
authors.initials: DM
authors.lastname: Pritchard
mesh_terms: D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology*; D005755:Gastrins / Q000378:metabolism*; D006801:Humans; D008024:Ligands; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D043887:Receptor, Cholecystokinin B / Q000819:agonists / Q000037:antagonists & inhibitors* / Q000235:genetics; D015398:Signal Transduction
chemical_list: D000970:Antineoplastic Agents; D005755:Gastrins; D008024:Ligands; D043887:Receptor, Cholecystokinin B